| View |
|
DR-XY19424
|
Cefalexin (As Monohydrate)
|
Cendalex
|
125 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
22 November 2022
|
27 December 2027
|
| View |
|
DR-XY19433-B
|
Mefenamic Acid
|
Algicap
|
500 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
11 April 2022
|
23 May 2027
|
| View |
|
DR-XY19456-B
|
Metoprolol Tartrate
|
Metospec
|
50 mg
|
Film-Coated Tablet
|
Beta-Adrenoceptor Blocker
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
28 May 2024
|
29 September 2029
|
| View |
|
DR-XY19458
|
Amoxicillin (as trihydrate)
|
Primex
|
100 mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterial (Penicillin with extended spectrum)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
05 October 2024
|
05 January 2030
|
| View |
|
DR-XY19467
|
Amoxicillin (as trihydrate)
|
Exbropin
|
250 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
20 October 2024
|
05 January 2030
|
| View |
|
DR-XY19469
|
Cefalexin (as Monohydrate)
|
Lorecep
|
100 mg/mL
|
Granule For Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
09 October 2024
|
05 January 2030
|
| View |
|
DR-XY19470
|
Cefalexin (as Monohydrate)
|
Lorecep
|
500 mg
|
Capsule
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
12 October 2024
|
06 January 2030
|
| View |
|
DR-XY19474
|
Paracetamol
|
Febrinil
|
150mg/mL
|
Solution For Injection (Im/Iv)
|
Analgesic/Antipyretic
|
Oboi Laboratories
|
India
|
Renewal
|
07 April 2024
|
09 August 2029
|
| View |
|
DR-XY19474-G
|
Paracetamol
|
Unbranded
|
150mg/mL
|
Solution For Injection (Im/Iv)
|
Analgesic/Antipyretic
|
Oboi Laboratories
|
India
|
Renewal
|
07 April 2024
|
03 August 2029
|
| View |
|
DR-XY19482-B
|
Mefenamic Acid
|
Icelax
|
500mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 May 2022
|
17 January 2027
|
| View |
|
DR-XY19513
|
Mesalazine
|
Salofalk
|
250mg
|
Rectal Suppository
|
Bowel Anti-inflammatory
|
Vifor AG Zweigniederlassung Medichemie
|
Switzerland
|
Renewal
|
29 September 2024
|
15 October 2029
|
| View |
|
DR-XY19524-B
|
Ranitidine Hydrochloride
|
Ulcerix
|
25mg/mL
|
Solution for Injection (I.M. /I.V.)
|
H2 Receptor Antagonist
|
Oboi Laboratories
|
India
|
Renewal
|
04 August 2024
|
23 January 2030
|
| View |
|
DR-XY19608
|
Cefalexin (As Monohydrate)
|
Airex
|
100mg/mL
|
Powder For Suspension (Oral Drops)
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
13 January 2022
|
12 February 2027
|
| View |
|
DR-XY19711
|
Mometasone Furoate
|
Elica
|
1 mg/g (0.1%)
|
Lotion
|
Anti-inflammatory / Antipruritic
|
Famar Montreal Inc.
|
Canada
|
Renewal
|
16 August 2024
|
26 October 2029
|
| View |
|
DR-XY19791-B
|
Chloramphenicol (as palmitate)
|
Sustachlor
|
125 mg/5 mL
|
Suspension
|
Antibacterial (Amphenicol)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 August 2022
|
10 October 2027
|
| View |
|
DR-XY19793
|
Paracetamol
|
Medgenol
|
100mg/ mL
|
Syrup (Oral Drops)
|
Analgesic / Antipyretic
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
Automatic Renewal
|
14 October 2021
|
15 September 2026
|
| View |
|
DR-XY19821
|
Carbocisteine
|
Cemetol
|
50mg/mL
|
Syrup (Oral Drops)
|
Mucolytics
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
19 January 2022
|
11 April 2027
|
| View |
|
DR-XY19832
|
Vitamin B1 + B6 + B12
|
Vibee
|
100mg/ 200mg/ 200mcg
|
Film-Coated Tablet
|
Vitamin
|
Biolab Co., Ltd.
|
Thailand
|
Automatic Renewal
|
05 January 2022
|
17 April 2027
|
| View |
|
DR-XY19833
|
Salbutamol (as Sulfate)
|
None
|
2mg/ 5mL
|
Syrup
|
Selective Beta-2-Adrenoreceptor Agonist
|
FORTIS MEDI PHARMACEUTICAL, INC.
|
Philippines
|
Renewal
|
28 April 2022
|
06 July 2027
|
| View |
|
DR-XY19867
|
Meclizine Hydrochloride
|
Bonamine
|
12.5 mg
|
Chewable Tablet
|
Anti-emetic
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
29 March 2024
|
21 October 2029
|